1,1‘-Binaphthyl Dimers, Oligomers, and Polymers: Molecular Recognition, Asymmetric Catalysis, and New Materials†

[R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-((1-­methylethyl)-3-phenyl-4-[(phenylamino)-carbonyl]-1H-­pyrrole-1-heptanoic acid or (2R-trans)-5-(4-fluorophenyl)-­2-(1-methylethyl-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-­oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide; a process for their preparation and pharmaceutically acceptable salts thereof.

(R-(R*R*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl-3-phenyl-4((phenylamino)-carbonyl)-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof

Efficient Separation of Enantiomers Using Stereoregular Chiral Polymers

Resolution of racemic compounds is one of the potential ways of obtaining both enantiomers. Among several resolution techniques in the past few decades, direct enantioseparation by high-performance liquid chromatography (HPLC) has significantly advanced, and a large number of chiral stationary phases (CSPs) for HPLC have been developed using both chiral small molecules and polymers with chiral recognition abilities. In this tutorial review, after describing the brief history and general view of CSPs, special emphasis will be placed on the studies involving the development and application of polysaccharide-based CSPs in our group.

Chiral HPLC for efficient resolution of enantiomers

Chirality is a ubiquitous feature in living systems. Today, it is widely recognized that many biologically interesting compounds, such as drugs, agrochemicals, food additives, and fragrances, are chiral and their physiological properties usually rely on their chirality due to the extremely high chiral discrimination ability of enzymes and receptors.1-6 Particularly, the different pharmacological effects between enantiomers are ultimately an important concern in the pharmaceutical field in which only one enantiomer of a chiral drug often exhibits the desirable therapeutic activity, while the other shows an antagonistic function, side effects, or even toxic effects.7-14 During the late 1950s and early 1960s, a racemate of N-phthalylglutamic acid imide, which is a sedative and hypnotic drug known as thalidomide, was administrated to pregnant women and caused the birth of approximately 10 000 babies with malformations. Later, Blaschke pointed out that this teratogenic effect was attributed to the S-(-)isomer.15 Even though the administration of the pure R-(+)isomer could not halt the disaster because thalidomide is unstable in the body and easily undergoes racemization,16-18 this tragedy undoubtedly brought a profound movement in the drug administration and industries. In 1992, the U.S. Food and Drug Administration issued a specific guideline for the production of new chiral drugs,19 which demanded a systematic investigation of the biological behavior of their individual enantiomers and significantly encouraged the development of single enantiomer drugs.20-22 Today, most of the best-selling drugs around the world are administered as single enantiomers with the desired therapeutic activity,23 and the annual sales of single enantiomer drugs are expected to exceed 200 billion dollars in 2008. Furthermore, the preparation of single enantiomers has also become important in the fields of functional materials, such as ferroelectric liquid crystals and organic nonlinear optical molecules.24-26 Based on this historical background, substantial efforts have been undertaken to develop practical techniques for the preparation of enantiomers with a high enantiomeric excess (ee). In general, two approaches are utilized for this objective, asymmetric synthesis and chiral separation. Asymmetric synthesis using chiral sources, such as chiral pools, chiral auxiliaries, asymmetric catalysts, and enzymes, has significantly progressed over the last few decades.27-41 Although the large-scale preparation of enantiomers can be economically attained using this approach, the products do not always show a high ee, and therefore, a further purification step may be inevitable. Additionally, nature produces only one of the enantiomers as a chiral source in most cases. This means that if both enantiomers of the target compounds are required, at least two kinds of chiral sources are necessary for each enantiomer. However, it is sometimes difficult to obtain both of them. On the other hand, the chiral separation approach can easily provide both enantiomers with a high ee. Since Pasteur first isolated two enantiomers of sodium ammonium tartrate using a magnifying glass and a pair of tweezers in 1848,42,43 the innovation of chiral separation techniques has attracted great interest. Basically, chiral separations44 are carried out by (i) crystallization,45-47 (ii) enzymatic kinetic resolution,48-50 and (iii) chromatographic separation.51-53 Specifically, direct chiral separation using chiral stationary phases (CSPs) for high-performance liquid chromatography (HPLC) has significantly evolved during the past few decades and is recognized as the most popular and reliable tool for both the analysis of enantiomer compositions and the preparation of pure enantiomers.51-64 Chiral separations can * To whom correspondence should be addressed. Mailing address: EcoTopia Science Institute, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 4648603, Japan. Phone: +81-52-789-4600. Fax: +81-52-789-3188. E-mail: okamoto@apchem.nagoya-u.ac.jp. † Nagoya University. ‡ Harbin Engineering University. Chem. Rev. 2009, 109, 6077–6101 6077

Structure control of polysaccharide derivatives for efficient separation of enantiomers by chromatography

Chromatographic optical resolution through chiral complexation of amino ester salts by a host covalently bound to silica gel

Total chromatographic optical resolutions of alpha-amino acid and ester salts through chiral recognition by a host covalently bound to polystyrene resin.

Y. Sogah

Papers

Chromatographic optical resolution through chiral complexation of amino ester salts by a host covalently bound to silica gel

Total chromatographic optical resolutions of alpha-amino acid and ester salts through chiral recognition by a host covalently bound to polystyrene resin.

Chromatographic optical resolution through chiral complexation of amino ester salts by a host covalently bound to silica gel